Stock Analysis·← Pickers

AVTR

Avantor, Inc.

Avantor, Inc. (AVTR) is currently in a range/mixed trend, trading above both the 50-day and 200-day moving averages. RSI is at 68.6, with 2/3 trend checks passing.

Price
$11.26
+0.06 (+0.54%)
Day range
$11.14–$11.43
52wk $7.26–$15.93
Volume
10.8M
Avg
Trend score
2/3
Range / Mixed
RSI (14)
68.6
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

AVTR with MA50 and MA200

15.6013.5511.509.467.4108/0110/2701/2304/2007/16
AVTR2025-08-012026-07-16
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$9.28+21.40% vs price
MA200
$10.31+9.23% vs price
RSI (14)
68.6Neutral zone
MACD Signal
BullishMomentum above signal
Macro Support
$10.62–$10.853.6% below price · 4 touches
Support Quality
4 touches1.4× zone volume
Valuation

AVTR valuation multiples (TTM)

P/E Ratio
P/S Ratio
P/B Ratio
EV/EBITDA
Valuation multiples are provided by Financial Modeling Prep when available.
Analyst Ratings

AVTR analyst consensus

Avg Price Target
High Target
Low Target
Analyst Coverage
Analyst ratings and price targets are provided by Financial Modeling Prep when available.
Chart Summary
Trend summary for AVTR

Avantor, Inc. (AVTR) looks more range-bound than strongly trending, but there are still a few supportive signs on the chart. The latest available price is $11.26, and 2 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 21.4% and above the 200-day moving average by 9.2%.

Momentum and stretch context

AVTR currently has an RSI reading of 68.6, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.

What traders may watch next

This page is designed to help you quickly understand what the AVTR chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Avantor, Inc.

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.

Share dilution

AVTR shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
678.0M
Since Jun 2019
+109.6%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. AVTR28 data points from Jun 2019 to Mar 2026.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Emmanuel Ligner
Employees
13,500
Market cap
$7.69B
Beta
0.94
52-week range
$7.26 – $15.93
Dividend
No
Exchange
NYSE
Country
US
IPO date
17 May 2019
ISIN
US05352A1007
CUSIP
05352A100
Company profile data from Financial Modeling Prep. AVTR listed on NYSE.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about AVTR

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.

AVTR Stock Analysis: Range/Mixed trend, above MA50 & MA200, RSI 69 | MyStockHarbor